Novartis AG (ADR) news

   Watch this stock
Showing stories 11 - 20 of about 152   

Articles published

NVS 103.57 -0.79 (-0.76%)
price chart
Novartis AG (ADR) (NYSE:NVS) Adds Spinifex Pharmaceuticals to its Portfolio
Novartis AG ADR (NYSE:NVS) recently announced that it will soon be acquiring a US-Australian biotech company called Spinifex Pharmaceuticals.
Novartis AG (ADR) (NVS) Looks At Performance Based Pricing System Ahead Of ...  InvestCorrectly
Novartis AG (ADR) Says Cosentyx Can Be A $5 Billion Drug After New Trial Data
Novartis AG (ADR) (NYSE:NVS) has updated its annual sales forecast for its potential blockbuster injectable drug Cosentyx (secukinumab), after new clinical data establishes the drug's long-term benefits in treating psoriatic arthritis.
Novartis' Cosentyx Positive in Psoriatic Arthritis Study - Analyst Blog  Yahoo News
Novartis AG (ADR) Expects Higher Profit Margin & Dividends This Year
Novartis AG (ADR) (NYSE:NVS) expects its profit margin to increase in 2015 on the back of a restructured drug portfolio and cost-cutting measures.
GlaxoSmithKline plc (ADR) (GSK), Novartis AG (ADR) (NVS), Sanofi SA (ADR) (SNY ...
The stocks include London-based GlaxoSmithKline plc (ADR) (NYSE:GSK), Switzerland-based Novartis AG (ADR) (NYSE:NVS) and France-based Sanofi SA (ADR) (NYSE:SNY).
GlaxoSmithKline scraps HIV spinout, reports higher Q1 profit  Proactive Investors USA & Canada
GlaxoSmithKline Plc (ADR) (NYSE:GSK) Unveils Big Business Growth Targets  WallStreetPR (blog)
Novartis AG (ADR) Biosimilar Blocked By US Appeals Court
The US Appeals court has blocked Novartis AG (ADR) (NYSE:NVS) from selling a copy of Amgen, Inc.'s (NASDAQ:AMGN) cancer supportive-care drug in the US for an indefinite period of time - or at least until June 3, when verbal arguments are scheduled, ...
Novartis AG (NVS) Stock Soars On Heart-Failure Drug Approval
The US Food and Drug Administration (FDA) has approved Novartis AG's (ADR) (NYSE:NVS) new heart-failure drug, Entresto, the agency announced in a press release on Tuesday.
Novartis AG (ADR) Launches Navigation App For Visually Impaired On Apple Watch ...
Novartis AG (ADR) (NYSE:NVS) has released a new smartphone app designed to allow visually impaired people easy navigation.
GlaxoSmithKline plc (ADR) To Close Asset Swap Deal With Novartis AG (ADR) Next ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) announced on Wednesday that it anticipates closing the mega-billion dollar asset exchange with Novartis AG (ADR) (NYSE:NVS) in the week beginning March 2, 2015. However, the deal, which is expected to make ...
Novartis AG (NYSE:NVS) & GlaxoSmithKline PLC (NYSE:GSK) Receive a Green ...  WallStreet.org
GlaxoSmithKline plc (ADR) And Novartis AG (ADR) Complete Three-Part Deal To ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) and Novartis AG (ADR) (NYSE:NVS) announced on Monday that the two companies have completed a series of complicated asset swaps worth $20 billion, in what appears to be a move to tidy up asset portfolios to ...
Asset Swaps Of Novartis AG (ADR) (NYSE:NVS) and GlaxoSmithKline plc (ADR ...  Stocks.org
GSK deal's done. Now, Novartis has to deliver on cancer-growth pledge  FiercePharma
Here's Why Novartis AG (ADR) Is Expected To See Soaring Top-Line Growth
Novartis AG (ADR) (NYSE:NVS) has seen its product sales suffer considerably since 2011 on the back of a patent cliff that hit the company's more than a decade-long blockbuster drug Diovan.